Literature DB >> 16825491

Cutaneous wound healing is impaired in hemophilia B.

Maureane Hoffman1, Anna Harger, Angela Lenkowski, Ulla Hedner, Harold R Roberts, Dougald M Monroe.   

Abstract

We used a mouse model to test the hypothesis that the time course and histology of wound healing is altered in hemophilia B. Punch biopsies (3 mm) were placed in the skin of normal mice and mice with hemophilia. The size of the wounds was measured daily until the epidermal defect closed. All wounds closed in mice with hemophilia by 12 days, compared with 10 days in normal animals. Skin from the area of the wound was harvested at different time points and examined histologically. Hemophilic animals developed subcutaneous hematomas; normal animals did not. Macrophage infiltration was significantly delayed in hemophilia B. Unexpectedly, hemophilic mice developed twice as many blood vessels in the healing wounds as controls, and the increased vascularity persisted for at least 2 weeks. The deposition and persistence of ferric iron was also greater in hemophilic mice. We hypothesize that iron plays a role in promoting excess angiogenesis after wounding as it had been proposed to do in hemophilic arthropathy. We have demonstrated that impaired coagulation leads to delayed wound healing with abnormal histology. Our findings have significant implications for treatment of patients with hemophilia, and also highlight the importance of rapidly establishing hemostasis following trauma or surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825491     DOI: 10.1182/blood-2006-05-020495

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Factor VII deficiency impairs cutaneous wound healing in mice.

Authors:  Zhi Xu; Haifeng Xu; Victoria A Ploplis; Francis J Castellino
Journal:  Mol Med       Date:  2010-02-11       Impact factor: 6.354

Review 2.  Wound healing in hemophilia B mice and low tissue factor mice.

Authors:  Dougald M Monroe; Nigel Mackman; Maureane Hoffman
Journal:  Thromb Res       Date:  2010-02-19       Impact factor: 3.944

3.  A new mouse model for wound healing in hemophilia A.

Authors:  Guangwei Gao; Dhahiri Saidi Mashausi; Hema Negi; Dongsheng Li; Dawei Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Red blood cell lysate modulates the expression of extracellular matrix proteins in dermal fibroblasts.

Authors:  Amir Akbari; Yunyuan Li; Ruhangiz T Kilani; Aziz Ghahary
Journal:  Mol Cell Biochem       Date:  2012-07-20       Impact factor: 3.396

5.  Platelet-like particles improve fibrin network properties in a hemophilic model of provisional matrix structural defects.

Authors:  Seema Nandi; Laura Sommerville; Kimberly Nellenbach; Emily Mihalko; Mary Erb; Donald O Freytes; Maureane Hoffman; Dougald Monroe; Ashley C Brown
Journal:  J Colloid Interface Sci       Date:  2020-05-26       Impact factor: 8.128

6.  Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

Authors:  Amy D Shapiro; Margaret V Ragni; Leonard A Valentino; Nigel S Key; Neil C Josephson; Jerry S Powell; Gregory Cheng; Arthur R Thompson; Jaya Goyal; Karen L Tubridy; Robert T Peters; Jennifer A Dumont; Donald Euwart; Lian Li; Bengt Hallén; Peter Gozzi; Alan J Bitonti; Haiyan Jiang; Alvin Luk; Glenn F Pierce
Journal:  Blood       Date:  2011-11-22       Impact factor: 22.113

Review 7.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

8.  IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia.

Authors:  N Narkbunnam; J Sun; G Hu; F-C Lin; T A Bateman; M Mihara; P E Monahan
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

9.  Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.

Authors:  Junjiang Sun; Baolai Hua; Xiaojing Chen; Richard J Samulski; Chengwen Li
Journal:  Hum Gene Ther       Date:  2017-05-05       Impact factor: 5.695

Review 10.  Microphysiological systems for the modeling of wound healing and evaluation of pro-healing therapies.

Authors:  Halston E Deal; Ashley C Brown; Michael A Daniele
Journal:  J Mater Chem B       Date:  2020-08-19       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.